These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 51533)

  • 41. Scintigraphic evidence of adrenal cortical dysfunction in the polycystic ovary syndrome.
    Gross MD; Wortsman J; Shapiro B; Meyers LC; Woodbury MC; Ayers JW
    J Clin Endocrinol Metab; 1986 Jan; 62(1):197-201. PubMed ID: 3079601
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.
    Gormley GJ; Stoner E; Bruskewitz RC; Imperato-McGinley J; Walsh PC; McConnell JD; Andriole GL; Geller J; Bracken BR; Tenover JS
    N Engl J Med; 1992 Oct; 327(17):1185-91. PubMed ID: 1383816
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Benign prostate syndrome: urinary tract symptoms can be eased with phytotherapy].
    Popa G; Hägele-Kaddour H; Walther C
    MMW Fortschr Med; 2005 Aug; 147(33-34):42. PubMed ID: 16138635
    [No Abstract]   [Full Text] [Related]  

  • 44. [A double-blind trial on the effect of bunazosin hydrochloride for the symptoms of benign prostatic hypertrophy].
    Kumamoto Y; Tsukamoto T; Yachiku S; Kaneko S; Koyanagi T; Togashi M; Maru A; Tsuchida S; Nishizawa O; Orikasa S
    Hinyokika Kiyo; 1990 Oct; 36(10):1213-32. PubMed ID: 1702262
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Characteristics of steroidogenesis in girls with different forms of sexual development retardation].
    Safaralieva AR; Rozovskiĭ IS; Bogdanova EA; Fanchenko ND; Berzina SV
    Akush Ginekol (Mosk); 1978 Oct; (10):34-8. PubMed ID: 717673
    [No Abstract]   [Full Text] [Related]  

  • 46. The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia.
    Weber JP; Oesterling JE; Peters CA; Partin AW; Chan DW; Walsh PC
    J Urol; 1989 Apr; 141(4):987-92. PubMed ID: 2467015
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Review of candidal vaginitis - use of candicidin in its treatment.
    Balin H
    Pa Med; 1974 Dec; 77(12):37-9. PubMed ID: 4618341
    [No Abstract]   [Full Text] [Related]  

  • 48. Endocrine studies on ovarian androblastomas (Sertoli-Leydig tumors).
    Munemura M; Inoue S; Himeno R; Koyama N; Mizumoto J; Maeyama M; Iwamasa T
    J Endocrinol Invest; 1984 Dec; 7(6):615-22. PubMed ID: 6099378
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Testosterone levels in benign prostatic hypertrophy and prostate cancer.
    Mearini L; Costantini E; Zucchi A; Mearini E; Bini V; Cottini E; Porena M
    Urol Int; 2008; 80(2):134-40. PubMed ID: 18362481
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of a synthetic 25 amino acid corticotrophin in normal man.
    Rose LI; Williams GH; Jagger PI; Lauler DP
    Clin Pharmacol Ther; 1968; 9(6):740-4. PubMed ID: 4301829
    [No Abstract]   [Full Text] [Related]  

  • 51. [Hypothalamo-hypophyseal-adrenal and hypothalamo-hypophyseal-gonadal interactions in young persons with different forms of male hypogonadism].
    Tomov T; Ankov V
    Vutr Boles; 1987; 26(6):81-8. PubMed ID: 2830720
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lack of effects of a lyposterolic extract of Serenoa repens on plasma levels of testosterone, follicle-stimulating hormone, and luteinizing hormone.
    Casarosa C; Cosci di Coscio M; Fratta M
    Clin Ther; 1988; 10(5):585-8. PubMed ID: 2485240
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Galactorrhea-amenorrhea due to primary hypothyroidism.
    Boroditsky RS; Faiman C
    Am J Obstet Gynecol; 1973 Jul; 116(5):661-5. PubMed ID: 4713129
    [No Abstract]   [Full Text] [Related]  

  • 54. [Data on the hematic conversion of testosterone into dihydrotestosterone in subjects with hypogonadism].
    Concolino G; Marocchi A; Sorcini G; Sciarra F
    Folia Endocrinol; 1973 Aug; 26(4):268-80. PubMed ID: 4801001
    [No Abstract]   [Full Text] [Related]  

  • 55. Metabolism of testosterone and dihydrotestosterone in the hirsute female.
    Concolino G; Marocchi A; Sciarra F; Sorcini G
    Folia Endocrinol; 1973 Aug; 26(4):293-307. PubMed ID: 4801004
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of synthetic luteinizing hormone releasing hormone (LH-RH) on the release of gonadotropins in Cushing's disease.
    Boccuzzi G; Angeli A; Bisbocci D; Fonzo D; Giadano GP; Ceresa F
    J Clin Endocrinol Metab; 1975 May; 40(5):892-5. PubMed ID: 1092712
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hormonal functions after bilateral ovariectomy and their relationship with postsurgical complaints].
    Miura S; Nakayamma M; Ishimaru T; Kase Y; Sugita Y
    Horumon To Rinsho; 1974 Oct; 22(10):1161-5. PubMed ID: 4475622
    [No Abstract]   [Full Text] [Related]  

  • 58. [Hormone determinations during 17-hydroxyprogesterone-capronate therapy].
    Sas M; Morvay J
    Zentralbl Gynakol; 1967 Oct; 89(43):1585-91. PubMed ID: 5590663
    [No Abstract]   [Full Text] [Related]  

  • 59. Dose-ranging study of the luteinizing hormone-releasing hormone receptor antagonist cetrorelix pamoate in the treatment of patients with symptomatic benign prostatic hyperplasia.
    Debruyne F; Tzvetkov M; Altarac S; Geavlete PA
    Urology; 2010 Oct; 76(4):927-33. PubMed ID: 20932411
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The inhibitory effect of an ergoline derivative (lergotrile, compound 83636) on prolactin secretion in man.
    Lemberger L; Crabtree R; Clemens J; Dyke RW; Woodburn RT
    J Clin Endocrinol Metab; 1974 Sep; 39(3):579-84. PubMed ID: 4416328
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.